Ridgewood, N.J.-based Valley Health System has opened the system's first compounding pharmacy. 

In a phase 3 trial spanning three years, weekly injections of tirzepatide reduced the risk of Type 2 diabetes by 94%, Eli Lilly said Aug. 20. 

The Board of Pharmacy Specialties is developing an exam for a new specialty pharmacy certification. 

Premier recently recognized six U.S. hospitals and health system pharmacies and one pharmacist through the company's 2024 Premier Pharmacy awards. 

Johnson & Johnson's oncology treatment regimen, Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib), is now approved as a first-line therapy, the drugmaker said Aug. 20. 

A context-aware ChatGPT might be of use in pharmacies, according to a recent study.

Northern Maine Medical Center in Fort Kent is moving its outpatient pharmacy services to St. John Valley Pharmacy, an independently owned pharmacy in the area.

An alternative option to appendectomies is becoming more mainstream, The Washington Post reported Aug. 17. 

Gabapentin is FDA-approved for epileptic seizures and postherpetic neuralgia, which is lasting pain after a shingles infection. Its off-label uses are climbing as physicians discover new applications, The New York Times reported Aug. 17. 

Denmark-based Bavarian Nordic said Aug. 17 it plans to ramp up mpox vaccine manufacturing.